Gene · 55540
IL17RB: interleukin 17 receptor B
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. IL17RB: interleukin 17 receptor B. Genes, record 55540. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55540
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NRM6 | Interleukin-17 receptor B | 502 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents307
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4731677 A2 | 2026-04-29 | 147 | Q9NRM6 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 50185 | Q9NRM6 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 3361 | Q9NRM6 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 169 | Q9NRM6 | Espacenet |
| EP 4641203 A2 | 2025-10-29 | 109 | Q9NRM6 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 2076 | Q9NRM6 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 2076 | Q9NRM6 | Espacenet |
| JP 2025517967 A | 2025-06-12 | 109 | Q9NRM6 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 3361 | Q9NRM6 | Espacenet |
| JP 2025508835 A | 2025-04-10 | 88 | Q9NRM6 | Espacenet |
1 to 10 of 307
See all 307 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,723
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IL17RB papers | Newest fiscal year |
|---|---|---|---|
| R01CA214608 | The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase | 18 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 15 | 2025 |
| P01CA066996 | Development of Novel Therapeutic Strategies in Human Leukemias | 12 | 2025 |
| P30CA044579 | University of Virginia Cancer Center Support Grant | 10 | 2025 |
| R01CA218278 | Degrading therapeutically important kinases using small molecules | 10 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 9 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| U01AI095608 | Regulation of mucosal immunity by neuronal pathways | 7 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 6 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 6 | 2025 |
1 to 10 of 1,723Source NIH's project files
See all 1,723 nih grantsPapers2,488
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis of diverse substrate recruitment by the HIV-1 Vpr-hijacked CRL4(VprBP) E3 ligase. | PLoS Pathog | 2026 | 42821551 | PubTator, text mining | PubMed |
| Therapeutic response to exclusive enteral nutrition correlates with suppressed IL-17 signaling activity and diminished IL-1β secretion in pediatric Crohn's disease. | Front Nutr | 2026 | 42807469 | PubTator, text mining | PubMed |
| Integrated bulk-single-cell transcriptomics identifies IL17RB as a candidate prognostic marker in colon cancer. | In Silico Pharmacol | 2026 | 42798395 | PubTator, text mining | PubMed |
| Gallic acid enhances radiosensitivity in pancreatic ductal adenocarcinoma models in association with CRL4-DCAF1-related CDK1 destabilization and ROS-associated DNA damage amplification. | Phytomedicine | 2026 | 42790317 | PubTator, text mining | PubMed |
| Breast Cancer Index and Recommendations for Extended Endocrine Therapy. | JAMA Netw Open | 2026 | 42783373 | PubTator, text mining | PubMed |
| TRI-611, a selective, brain-penetrant molecular glue degrader of ALK. | Nature | 2026 | 42717093 | PubTator, text mining | PubMed |
| Topology Resetting During Transcription-Coupled Nucleotide Excision Repair. | Int J Mol Sci | 2026 | 42653251 | PubTator, text mining | PubMed |
| Construction and validation of a nomogram for the diagnosis of postmenopausal osteoporosis. | Mol Med Rep | 2026 | 42596822 | PubTator, text mining | PubMed |
| Integrated Transcriptomic Analysis of NOTCH1- and MYB-Associated Immune Features in SACC. | Int J Mol Sci | 2026 | 42511840 | PubTator, text mining | PubMed |
| RepID orchestrates CDH1 and CTNNB1 homeostasis to regulate metastatic potential in small cell lung cancer. | Biochem Biophys Res Commun | 2026 | 42485799 | PubTator, text mining | PubMed |
1 to 10 of 2,488
See all 2,488 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/55540
GET https://conductscience.org/api/genes/v1/55540/patents?page=2